Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes
详细信息 查看全文
- 作者：Meagan Griffin ; PharmDa ; Desiree E. Kosmisky ; PharmDc ; Megan A. Templin ; MPH ; MSc ; Toan Huynh ; MDb ; Lewis H. McCurdy III ; MDb ; Timothy R. Pasquale ; PharmDb ; Kelly E. Martin ; PharmDb ; Kelly.Martin@CarolinasHealthcare.org" class="auth_mail" title="E-mail the corresponding author
- 关键词：Candida ; Yeast ; Bronchoscopy ; Antifungal agents ; Pneumonia
- 刊名：Heart & Lung: The Journal of Acute and Critical Care
- 出版年：2016
- 出版时间：November-December 2016
- 年：2016
- 卷：45
- 期：6
- 页码：538-543
- 全文大小：287 K
文摘
- •
Candida from a bronchoalveolar lavage (BAL) culture usually represents colonization.
- •
Antifungal treatment of Candida from a BAL does not improve clinical outcomes.
- •
Not recommended to treat Candida from a BAL in immunocompetent patients.